KALA BIO Statistics

Total Valuation

KALA BIO has a market cap or net worth of $19.74 million. The enterprise value is $1.72 million.

Market Cap	19.74M
Enterprise Value	1.72M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

KALA BIO has 6.45 million shares outstanding. The number of shares has increased by 56.09% in one year.

Current Share Class	6.45M
Shares Outstanding	6.45M
Shares Change (YoY)	+56.09%
Shares Change (QoQ)	+1.45%
Owned by Insiders (%)	3.05%
Owned by Institutions (%)	20.19%
Float	3.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.45
P/TBV Ratio	1.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.11, with a Debt / Equity ratio of 2.62.

Current Ratio	3.11
Quick Ratio	3.02
Debt / Equity	2.62
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.99

Financial Efficiency

Return on equity (ROE) is -388.29% and return on invested capital (ROIC) is -57.17%.

Return on Equity (ROE)	-388.29%
Return on Assets (ROA)	-45.36%
Return on Invested Capital (ROIC)	-57.17%
Return on Capital Employed (ROCE)	-104.95%
Revenue Per Employee	n/a
Profits Per Employee	-$1.01M
Employee Count	38
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.66% in the last 52 weeks. The beta is -1.72, so KALA BIO's price volatility has been lower than the market average.

Beta (5Y)	-1.72
52-Week Price Change	-51.66%
50-Day Moving Average	5.98
200-Day Moving Average	6.47
Relative Strength Index (RSI)	25.18
Average Volume (20 Days)	44,944

Short Selling Information

The latest short interest is 266,053, so 4.12% of the outstanding shares have been sold short.

Short Interest	266,053
Short Previous Month	274,816
Short % of Shares Out	4.12%
Short % of Float	6.91%
Short Ratio (days to cover)	13.04

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-40.43M
Pretax Income	-38.72M
Net Income	-38.51M
EBITDA	-40.18M
EBIT	-40.43M
Earnings Per Share (EPS)	-$10.15

Full Income Statement

Balance Sheet

The company has $51.18 million in cash and $32.25 million in debt, giving a net cash position of $18.93 million or $2.93 per share.

Cash & Cash Equivalents	51.18M
Total Debt	32.25M
Net Cash	18.93M
Net Cash Per Share	$2.93
Equity (Book Value)	12.33M
Book Value Per Share	2.02
Working Capital	35.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.38 million and capital expenditures -$208,000, giving a free cash flow of -$29.59 million.

Operating Cash Flow	-29.38M
Capital Expenditures	-208,000
Free Cash Flow	-29.59M
FCF Per Share	-$4.59

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KALA BIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-56.09%
Shareholder Yield	-56.09%
Earnings Yield	-186.51%
FCF Yield	-143.31%

Analyst Forecast

The average price target for KALA BIO is $15.00, which is 390.20% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	390.20%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 21, 2022. It was a reverse split with a ratio of 0.02:1.

Last Split Date	Oct 21, 2022
Split Type	Reverse
Split Ratio	0.02:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2